Chronic myeloid leukaemia and Recurrent cancer

Summary:

Recurrent cancer is found among people with Chronic myeloid leukaemia, especially for people who are male, 60+ old.

The study analyzes which people have Recurrent cancer with Chronic myeloid leukaemia. It is created by eHealthMe based on reports of 29 people who have Chronic myeloid leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Chronic myeloid leukaemia?

Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood) is found to be associated with 319 drugs and 443 conditions by eHealthMe. Check the latest studies of Chronic myeloid leukaemia.

What is Recurrent cancer?

Recurrent cancer (repeated cancer) is found to be associated with 366 drugs and 432 conditions by eHealthMe. Check the latest studies of Recurrent cancer.



On Jul, 20, 2026

29 people who have Chronic Myeloid Leukaemia and Recurrent Cancer are studied.

Would you have Recurrent cancer when you have Chronic myeloid leukaemia?

Gender of people who have Chronic Myeloid Leukaemia and experienced Recurrent Cancer *:

  • female: 36.36 %
  • male: 63.64 %

Age of people who have Chronic Myeloid Leukaemia and experienced Recurrent Cancer *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.69 %
  • 50-59: 15.38 %
  • 60+: 69.23 %

Common co-existing conditions for these people *:

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 17.24%
  2. Pain: 3 people, 10.34%
  3. Diabetes: 3 people, 10.34%
  4. Blast Crisis In Myelogenous Leukaemia: 2 people, 6.90%
  5. Gastrointestinal Stromal Tumor: 1 person, 3.45%

Common drugs taken by these people *:

  1. Glivec: 7 people, 24.14%
  2. Eliquis: 6 people, 20.69%
  3. Atorvastatin Calcium: 5 people, 17.24%
  4. Hydrocodone Bitartrate: 5 people, 17.24%
  5. Hydroxyzine Pamoate: 5 people, 17.24%
  6. Lasix: 5 people, 17.24%
  7. Methocarbamol: 5 people, 17.24%
  8. Allopurinol: 5 people, 17.24%
  9. Pravastatin Sodium: 5 people, 17.24%
  10. Amlodipine Besylate: 5 people, 17.24%

Common symptoms for these people *:

  1. Headache (pain in head): 8 people, 27.59%
  2. Nausea (feeling of having an urge to vomit): 8 people, 27.59%
  3. Peripheral Swelling: 7 people, 24.14%
  4. Weight Decreased: 7 people, 24.14%
  5. Drug Ineffective: 6 people, 20.69%
  6. Migraine (headache): 6 people, 20.69%
  7. Joint Swelling: 6 people, 20.69%
  8. White Blood Cell Count Abnormal: 6 people, 20.69%
  9. Pain: 6 people, 20.69%
  10. Bone Pain: 6 people, 20.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Recurrent cancer?

- Check whether Recurrent cancer is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Recurrent cancer:

All the conditions that are associated with Recurrent cancer:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Recurrent cancer and Chronic myeloid leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: